Veloxis Pharmaceuticals A/S, of Copenhagen, said its U.S. subsidiary inked an exclusive license, supply and distribution agreement with Taiba Healthcare, of Muscat, Oman, to register, commercialize and distribute Envarsus XR (tacrolimus) in certain countries throughout the Middle East and North Africa, or MENA, region.